Search results for "RNA virus"

showing 10 items of 149 documents

An unusually high substitution rate in transplant-associated BK polyomavirus in vivo is further concentrated in HLA-C-bound viral peptides

2018

Infection with human BK polyomavirus, a small double-stranded DNA virus, potentially results in severe complications in immunocompromised patients. Here, we describe the in vivo variability and evolution of the BK polyomavirus by deep sequencing. Our data reveal the highest genomic evolutionary rate described in double-stranded DNA viruses, i.e., 10−3–10−5 substitutions per nucleotide site per year. High mutation rates in viruses allow their escape from immune surveillance and adaptation to new hosts. By combining mutational landscapes across viral genomes with in silico prediction of viral peptides, we demonstrate the presence of significantly more coding substitutions within predicted cog…

RNA viruses0301 basic medicineMutation ratePhysiologyvirusesUrinePathology and Laboratory Medicinemedicine.disease_causeBiochemistryMedicine and Health SciencesBiology (General)Amino AcidsGenome EvolutionPhylogenyData ManagementMutationOrganic CompoundsHigh-Throughput Nucleotide SequencingPhylogenetic AnalysisDNA virusGenomicsBody FluidsBK virusPhylogeneticsChemistryMedical MicrobiologyViral PathogensViral evolutionVirusesPhysical SciencesEvolutionary RatePathogensAnatomyResearch ArticleComputer and Information SciencesEvolutionary ProcessesQH301-705.5ImmunologyGenome ViralHLA-C AntigensBiologyMicrobiologyMolecular EvolutionViral EvolutionVirusDeep sequencing03 medical and health sciencesVirologyGeneticsmedicineHumansEvolutionary SystematicsMicrobial PathogensMolecular BiologyTaxonomyEvolutionary BiologyPolyomavirus InfectionsOrganic ChemistryOrganismsChemical CompoundsBiology and Life SciencesComputational BiologyProteinsOrgan TransplantationRC581-607030112 virologyVirologyOrganismal EvolutionPeptide FragmentsPolyomaviruses030104 developmental biologyAmino Acid SubstitutionBK VirusMicrobial EvolutionMutationParasitologyImmunologic diseases. AllergyDNA virusesPolyomavirus Infections
researchProduct

Human norovirus binding to select bacteria representative of the human gut microbiota

2016

Recent reports describe the ability of select bacterial strains to bind human norovirus, although the specificity of such interactions is unknown. The purpose of this work was to determine if a select group of bacterial species representative of human gut microbiota bind to human norovirus, and if so, to characterize the intensity and location of that binding. The bacteria screened included naturally occurring strains isolated from human stool (Klebsiella spp., Citrobacter spp., Bacillus spp., Enterococcus faecium and Hafnia alvei) and select reference strains (Staphylococcus aureus and Enterobacter cloacae). Binding in PBS was evaluated to three human norovirus strains (GII.4 New Orleans 2…

RNA viruses0301 basic medicinePhysiologyvirusesEnterococcus faeciumFimbrialcsh:MedicineBacillusPathology and Laboratory Medicinemedicine.disease_causePilusFecesBinding AnalysisCitrobacterKlebsiellaMedicine and Health SciencesElectron Microscopylcsh:ScienceCitrobacterMicroscopyMultidisciplinarybiologyChemistryBody FluidsBloodMedical MicrobiologyViral PathogensVirusesAnaerobic bacteriaPathogensAnatomyCell Binding AssayResearch ArticleCell BindingStaphylococcus aureusCell PhysiologyAnaerobic BacteriaResearch and Analysis MethodsMicrobiologyCalicivirusesMicrobiology03 medical and health sciencesEnterobacter cloacaemedicineHumansMicrobial PathogensChemical CharacterizationBiology and life sciencesBacteriaNoroviruslcsh:ROrganismsHafnia alveiCell Biologybiology.organism_classificationCulture MediaGastrointestinal Microbiome030104 developmental biologyFimbriae BacterialNorovirusMicrobial InteractionsTransmission Electron Microscopylcsh:QEnterobacter cloacaeBacteriaEnterococcus faeciumPLOS ONE
researchProduct

Cost-Effectiveness Analysis of Different Testing Strategies that Use Antibody Levels to Detect Chronic Hepatitis C in Blood Donors.

2016

Aim. We conducted a cost-effectiveness analysis of seven hepatitis C virus (HCV) testing strategies in blood donors. Methods. Three of the seven strategies were based on HCV diagnosis and reporting guidelines in Mexico and four were from previous and current recommendations outlined by the CDC. The strategies that were evaluated determine antibody levels according to the signal-to-cut-off (S/CO) ratio and use reflex Immunoblot (IMB) or HCV RNA tests to confirm true positive (TP) cases of chronic HCV infection. Costs were calculated from the perspective of the Mexican Institute of Social Security (IMSS). A decision tree model was developed to estimate the expected number of true positive cas…

RNA virusesDecision AnalysisPhysiologyEconomicsCost-Benefit AnalysisSocial Scienceslcsh:MedicineBlood DonorsHepacivirusmedicine.disease_causeBiochemistryHepatitis0302 clinical medicineImmune Physiology030212 general & internal medicineChroniclcsh:SciencePathology and laboratory medicinehealth care economics and organizationsMultidisciplinaryImmune System ProteinsCost–benefit analysisHepatitis C virusLiver DiseaseCost-effectiveness analysisMedical microbiologyHepatitis CHCV AntibodyInfectious DiseasesVirusesEngineering and TechnologyBlood Banks030211 gastroenterology & hepatologyPathogensInfectionManagement EngineeringResearch Articlemedicine.medical_specialtyGeneral Science & TechnologyHepatitis C virusImmunologyCost-Effectiveness AnalysisImmunoblottingChronic Liver Disease and CirrhosisMolecular Probe TechniquesAntibody levelResearch and Analysis MethodsMicrobiologyAntibodies03 medical and health sciencesChronic hepatitisHepatitis - CClinical ResearchInternal medicineparasitic diseasesmedicineHumansImmunoassaysMolecular Biology TechniquesSensitivity analysesMolecular BiologyMedicine and health sciencesBiology and life sciencesFlavivirusesbusiness.industryDecision Treeslcsh:RHepatitis C antibodyOrganismsViral pathogensProteinsHepatitis C ChronicHepatitis C AntibodiesHepatitis virusesEconomic AnalysisMicrobial pathogensHealth CareEmerging Infectious DiseasesCost Effectiveness ResearchHealth Care FacilitiesImmunologyImmunologic Techniqueslcsh:QbusinessDigestive Diseases
researchProduct

The contribution of epistasis to the architecture of fitness in an RNA virus

2004

4 pages, 2 figures.-- PMID: 15492220 [PubMed].-- PMCID: PMC524436.-- Additional information (Suppl. table S1: Relevant information about each single- and double-nucleotide substitution mutant created) available at: http://www.pnas.org/content/101/43/15376/suppl/DC1

RNA virusesGeneticsDNA ComplementaryMultidisciplinarybiologyEpistasis and functional genomicsRNAEpistasis GeneticEvolutionary biologyRNA virusBiological Sciencesbiology.organism_classificationGenomeInteractions among genome componentsVesicular stomatitis virusFitnessFisher's geometric modelGenotypeMutagenesis Site-DirectedEpistasisRNA VirusesEpistasisCloning MolecularMutationsProceedings of the National Academy of Sciences
researchProduct

Protection against myxomatosis and rabbit viral hemorrhagic disease with recombinant myxoma viruses expressing rabbit hemorrhagic disease virus capsi…

1996

Two myxoma virus-rabbit hemorrhagic disease virus (RHDV) recombinant viruses were constructed with the SG33 strain of myxoma virus to protect rabbits against myxomatosis and rabbit viral hemorrhagic disease. These recombinant viruses expressed the RHDV capsid protein (VP60). The recombinant protein, which is 60 kDa in size, was antigenic, as revealed by its reaction in immunoprecipitation with antibodies raised against RHDV. Both recombinant viruses induced high levels of RHDV- and myxoma virus-specific antibodies in rabbits after immunization. Inoculations by the intradermal route protected animals against virulent RHDV and myxoma virus challenges.

RNA virusesHemorrhagic Disease Virus Rabbitanimal diseasesvirusesLeporipoxviruslaw.invention0403 veterinary sciencelawVIRUS RECOMBINEComputingMilieux_MISCELLANEOUSCaliciviridae Infections[SDV.MP.VIR] Life Sciences [q-bio]/Microbiology and Parasitology/Virology0303 health sciencesVaccines SyntheticMyxomatosisLagovirus04 agricultural and veterinary sciences3. Good healthLagovirusCapsid[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/VirologyRecombinant DNAcardiovascular systemRabbitsReassortant VirusesLeporipoxvirusResearch Article040301 veterinary sciencesImmunologyDNA RecombinantMyxoma virusBiologyMicrobiologyVirus03 medical and health sciencesMyxomatosis InfectiousImmunity reactionsVirologyReassortant VirusesmedicineAnimalsRabbit diseasesRecombinant vaccinescardiovascular diseasesImmune response030304 developmental biologyViral Structural ProteinsViral infectionsMyxoma virusbiology.organism_classificationmedicine.diseaseVirologyMédecine vétérinaire et santé animalInsect ScienceExperimental infectionsDNA ViralDNA virusesJournal of virology
researchProduct

APOBEC4 Enhances the Replication of HIV-1

2016

APOBEC4 (A4) is a member of the AID/APOBEC family of cytidine deaminases. In this study we found a high mRNA expression of A4 in human testis. In contrast, there were only low levels of A4 mRNA detectable in 293T, HeLa, Jurkat or A3.01 cells. Ectopic expression of A4 in HeLa cells resulted in mostly cytoplasmic localization of the protein. To test whether A4 has antiviral activity similar to that of proteins of the APOBEC3 (A3) subfamily, A4 was co-expressed in 293T cells with wild type HIV-1 and HIV-1 luciferase reporter viruses. We found that A4 did not inhibit the replication of HIV-1 but instead enhanced the production of HIV-1 in a dose-dependent manner and seemed to act on the viral L…

RNA virusesMale0301 basic medicineMolecular biologylcsh:MedicineArtificial Gene Amplification and ExtensionCytidinePathology and Laboratory MedicineVirus ReplicationBiochemistryPolymerase Chain ReactionJurkat cellschemistry.chemical_compoundCytidine deaminationImmunodeficiency VirusesTranscription (biology)TestisMedicine and Health Scienceslcsh:SciencePromoter Regions GeneticMultidisciplinaryCytidineTransfectionEnzymesImmunoblot AnalysisMedical MicrobiologyDeaminationViral PathogensViruses293T cellsCell linesPathogensOxidoreductasesBiological culturesLuciferaseResearch ArticleMolecular Probe TechniquesDNA constructionBiologyMicrobiologyCell Line03 medical and health sciencesCytidine DeaminaseRetrovirusesHumansMicrobial PathogensHIV Long Terminal Repeat030102 biochemistry & molecular biologylcsh:RLentivirusHEK 293 cellsOrganismsBiology and Life SciencesHIVProteinsPromoterMolecular biologyResearch and analysis methodsMolecular biology techniques030104 developmental biologychemistryPlasmid ConstructionHIV-1Enzymologylcsh:QEctopic expressionCloningPLOS ONE
researchProduct

Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled…

2017

Dysbalance in gut microbiota has been linked to increased microbial translocation, leading to chronic inflammation in HIV-patients, even under effective HAART. Moreover, microbial translocation is associated with insufficient reconstitution of CD4+T cells, and contributes to the pathogenesis of immunologic non-response. In a double-blind, randomised, placebo-controlled trial, we recently showed that, compared to placebo, 12 weeks treatment with probiotic Saccharomyces boulardii significantly reduced plasma levels of bacterial translocation (Lipopolysaccharide-binding protein or LBP) and systemic inflammation (IL-6) in 44 HIV virologically suppressed patients, half of whom (n = 22) had immun…

RNA virusesMale0301 basic medicinePlacebo-controlled studylcsh:MedicineHIV InfectionsGut floraPathology and Laboratory MedicineSystemic inflammationlaw.inventionPlacebosProbiotic0302 clinical medicineImmunodeficiency ViruseslawMedicine and Health SciencesMedicinelcsh:ScienceImmune ResponseMultidisciplinarybiologyMicrobiotaGenomicsMiddle AgedProbiòticsBacterial PathogensIntestinesSaccharomyces boulardiiMedical MicrobiologyViral PathogensVirusesFemale030211 gastroenterology & hepatologyPathogensmedicine.symptomResearch ArticleSaccharomyces boulardiiAdultImmunologyMicrobial GenomicsMicrobiologySaccharomyces03 medical and health sciencesSigns and SymptomsImmune systemDouble-Blind MethodDiagnostic MedicineRetrovirusesGeneticsVIH (Virus)HumansMicrobiomeMicrobial PathogensInflammationClostridiumBacteriabusiness.industryProbioticsGut BacteriaLentivirusLachnospiraceaelcsh:ROrganismsFungiBiology and Life SciencesHIVbiology.organism_classificationYeast030104 developmental biologyImmunologylcsh:QMicrobiomebusinessPLoS ONE
researchProduct

An Open-Label Trial of 12-Week Simeprevir plus Peginterferon/Ribavirin (PR) in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 1 (GT1)

2016

Background: Shortening duration of peginterferon-based HCV treatment reduces associated burden for patients. Primary objectives of this study were to assess the efficacy against the minimally acceptable response rate 12 weeks post-treatment (SVR12) and safety of simeprevir plus PR in treatment-naïve HCV GT1 patients treated for 12 weeks. Additional objectives included the investigation of potential associations of rapid viral response and baseline factors with SVR12. Methods: In this Phase III, open-label study in treatment-naïve HCV GT1 patients with F0-F2 fibrosis, patients with HCV-RNA 12-week regimen. Conclusions: Overall SVR12 rate (66%) was below the target of 80%, indicating that sho…

RNA virusesMale0301 basic medicineSimeprevirDecision AnalysisPsychologie appliquéelcsh:MedicineHepacivirusmedicine.disease_causeTherapy naivechemistry.chemical_compoundMathematical and Statistical Techniques0302 clinical medicineRecurrenceSimeprevirlcsh:SciencePathology and laboratory medicineMultidisciplinaryHepatitis C virusPharmaceuticsHepatitis CMedical microbiologyViral LoadMiddle AgedSciences bio-médicales et agricolesPEGINTERFERON/RIBAVIRINHepatitis C3. Good healthTreatment OutcomeResearch DesignVirusesPhysical SciencesRegression AnalysisEngineering and TechnologyFemale030211 gastroenterology & hepatologyPathogensManagement EngineeringBiologieViral loadStatistics (Mathematics)HumanResearch ArticleAdultmedicine.medical_specialtyGenotypeClinical Research DesignHepatitis C virusResearch and Analysis MethodsMicrobiologyAntiviral AgentsYoung Adult03 medical and health sciencesDrug TherapyVirologyRibavirinmedicineHumansddc:610Statistical MethodsAgedAntiviral AgentMedicine and health sciencesHepaciviruFlavivirusesbusiness.industryRibavirinDecision Treeslcsh:ROrganismsViral pathogensBiology and Life Sciencesmedicine.diseaseFibrosisVirologyHepatitis virusesMicrobial pathogensClinical trial030104 developmental biologychemistryFamily medicineMultivariate Analysislcsh:QAdverse EventsbusinessMathematicsViral Transmission and InfectionDevelopmental BiologyPLOS ONE
researchProduct

A model for rapid, active surveillance for medically-attended acute gastroenteritis within an integrated health care delivery system

2018

Background This study presents a novel methodology for estimating all-age, population-based incidence rates of norovirus and other pathogens that contribute to acute gastroenteritis in the United States using an integrated healthcare delivery system as a surveillance platform. Methods All cases of medically attended acute gastroenteritis within the delivery system were identified from April 1, 2014 through September 30, 2016. A sample of these eligible patients were selected to participate in two phone-based surveys and to self-collect a stool sample for laboratory testing. To ascertain household transmission patterns, information on household members with acute gastroenteritis was gathered…

RNA virusesMale0301 basic medicineTime FactorsEpidemiologyEthnic grouplcsh:MedicineSurveysPathology and Laboratory Medicinemedicine.disease_causeGeographical locationsOregonFeces0302 clinical medicineEpidemiologyMedicine and Health SciencesSampling (medicine)030212 general & internal medicineChildlcsh:Scienceeducation.field_of_studyMultidisciplinaryDelivery of Health Care IntegratedMiddle AgedTelephonesGastroenteritisDiarrheaInfectious DiseasesResearch DesignMedical MicrobiologyViral PathogensChild PreschoolVirusesEpidemiological MonitoringEngineering and TechnologyFemalePathogensEpidemiological Monitoringmedicine.symptomResearch ArticleDiarrheaAdultmedicine.medical_specialtyInfectious Disease ControlAdolescent030106 microbiologyPopulationEquipmentSample (statistics)Gastroenterology and HepatologyDisease SurveillanceResearch and Analysis MethodsMicrobiologyCalicivirusesYoung Adult03 medical and health sciencesSigns and SymptomsDiagnostic MedicinemedicineHumanseducationMicrobial PathogensAgedCommunication EquipmentSurvey Researchbusiness.industryNoroviruslcsh:ROrganismsBiology and Life SciencesUnited StatesInfectious Disease SurveillanceFamily medicineNorth AmericaNorovirusFeasibility Studieslcsh:QPeople and placesbusinessFollow-Up StudiesPLOS ONE
researchProduct

Vertical transmission of naturally occurring Bunyamwera and insect-specific flavivirus infections in mosquitoes from islands and mainland shores of L…

2018

Background Many arboviruses transmitted by mosquitoes have been implicated as causative agents of both human and animal illnesses in East Africa. Although epidemics of arboviral emerging infectious diseases have risen in frequency in recent years, the extent to which mosquitoes maintain pathogens in circulation during inter-epidemic periods is still poorly understood. This study aimed to investigate whether arboviruses may be maintained by vertical transmission via immature life stages of different mosquito vector species. Methodology We collected immature mosquitoes (egg, larva, pupa) on the shores and islands of Lake Baringo and Lake Victoria in western Kenya and reared them to adults. Mo…

RNA virusesMale0301 basic medicineViral DiseasesAnopheles GambiaevirusesAnopheles gambiaeRC955-962Marine and Aquatic SciencesDisease VectorsPathology and Laboratory MedicineMosquitoes0302 clinical medicineAedesArctic medicine. Tropical medicineMedicine and Health SciencesChikungunya VirusbiologyPupaAnophelesEukaryotavirus diseasesGene PoolInsectsCulexInfectious DiseasesArboviral InfectionsMedical MicrobiologyViral PathogensLarvaVirusesFemalePublic aspects of medicineRA1-1270PathogensResearch ArticleFreshwater EnvironmentsArthropodaAlphaviruses030231 tropical medicineZoologyMosquito VectorsAedes aegyptiAedes AegyptiMicrobiologyArbovirusTogaviruses03 medical and health sciencesAedes luteocephalusSpecies SpecificityAnophelesparasitic diseasesCulex pipiensGeneticsmedicineAnimalsBunyamwera virusMicrobial PathogensAedesEvolutionary BiologyLife Cycle StagesPopulation BiologyFlavivirusEcology and Environmental SciencesfungiOrganismsPublic Health Environmental and Occupational HealthBiology and Life SciencesAquatic EnvironmentsBodies of Watermedicine.diseasebiology.organism_classificationInvertebratesKenyaInsect VectorsSpecies InteractionsLakes030104 developmental biologyVector (epidemiology)Earth SciencesArbovirusesPopulation GeneticsPLOS Neglected Tropical Diseases
researchProduct